Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

456 ARTÍCULOS , VIENDO DEL 76 AL 90

Absence of rapid eye movement sleep with hypnopompic visual hallucinations: a possible harbinger of dementia with Lewy bodies?

Tiraboschi P, Jann S, Didato G, Nobili L, Proserpio P.

Sleep Med. 2013 Apr;14(4):377-9. doi: 10.1016/j.sleep.2013.01.005. Epub 2013 Feb 28.

Chronic neuropathologies of single and repetitive TBI: substrates of dementia?

Smith DH, Johnson VE, Stewart W.

Nat Rev Neurol. 2013 Apr;9(4):211-21. doi: 10.1038/nrneurol.2013.29. Epub 2013 Mar 5.

What can memory tests predict about the aging brain? The freedom to recall

Wright CB, Zonderman AB.

Neurology. 2013 Apr 2;80(14):1274-5. doi: 10.1212/WNL.0b013e31828ab392. Epub 2013 Mar 6.

A cortical pathway to olfactory naming: evidence from primary progressive aphasia

Olofsson JK, Rogalski E, Harrison T, Mesulam MM, Gottfried JA.

Brain. 2013 Apr;136(Pt 4):1245-59. doi: 10.1093/brain/awt019. Epub 2013 Mar 7.

A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease

Herrmann N, Gauthier S, Boneva N, Lemming OM; 10158 Investigators.

Int Psychogeriatr. 2013 Jun;25(6):919-27. doi: 10.1017/S1041610213000239. Epub 2013 Mar 8.

Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease

Johansson P, Åberg D, Johansson JO, Mattsson N, Hansson O, Ahrén B, Isgaard J, Åberg ND, Blennow K, Zetterberg H, Wallin A, Svensson J.

Psychoneuroendocrinology. 2013 Sep;38(9):1729-37. doi: 10.1016/j.psyneuen.2013.02.006. Epub 2013 Mar 6.

Does the Framingham cardiovascular disease risk score also have predictive utility for dementia death? An individual participant meta-analysis of 11,887 men and women

Russ TC, Hamer M, Stamatakis E, Starr JM, Batty GD, Kivimäki M.

Atherosclerosis. 2013 May;228(1):256-8. doi: 10.1016/j.atherosclerosis.2013.02.020. Epub 2013 Feb 26.

Comparing brain amyloid deposition, glucose metabolism, and atrophy in mild cognitive impairment with and without a family history of dementia

Mosconi L, Andrews RD, Matthews DC.

J Alzheimers Dis. 2013;35(3):509-24. doi: 10.3233/JAD-121867.

Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease

Glodzik L, Randall C, Rusinek H, de Leon MJ.

J Alzheimers Dis. 2013;35(3):427-40. doi: 10.3233/JAD-122011.

Correlation of specific amyloid-β oligomers with tau in cerebrospinal fluid from cognitively normal older adults

Handoko M, Grant M, Kuskowski M, Zahs KR, Wallin A, Blennow K, Ashe KH.

JAMA Neurol. 2013 May;70(5):594-9. doi: 10.1001/jamaneurol.2013.48.

Equal sensitivity of early and late scans after injection of FDG for the detection of Alzheimer pattern: an analysis of 3D PET data from J-ADNI, a multi-center study

Takahashi R, Ishii K, Senda M, Ito K, Ishii K, Kato T, Makishi Y, Nishio T, Ikari Y, Iwatsubo T; Japanese Alzheimer’s Disease Neuroimaging Initiative.

Ann Nucl Med. 2013 Jun;27(5):452-9. doi: 10.1007/s12149-013-0704-x. Epub 2013 Mar 13.

Cognitive impairment and diabetes

Dash SK.

Recent Pat Endocr Metab Immune Drug Discov. 2013 May;7(2):155-65. doi: 10.2174/1872214811307020009.

Are there susceptibility factors for primary progressive aphasia?

Rogalski E, Weintraub S, Mesulam MM.

Brain Lang. 2013 Nov;127(2):135-8. doi: 10.1016/j.bandl.2013.02.004. Epub 2013 Mar 13.

Psychiatry looks towards the future in neurodegenerative and neurodevelopmental disorders

Sachdev PS.

Curr Opin Psychiatry. 2013 May;26(3):237-8. doi: 10.1097/YCO.0b013e32835fd70e.

Utility of the AD8 as a self-rating tool for cognitive impairment in an Asian population

Chin R, Ng A, Narasimhalu K, Kandiah N.

Am J Alzheimers Dis Other Demen. 2013 May;28(3):284-8. doi: 10.1177/1533317513481090. Epub 2013 Mar 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias